Live Breaking News & Updates on Orbicular pharmaceutical technologies pvt

Stay informed with the latest breaking news from Orbicular pharmaceutical technologies pvt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Orbicular pharmaceutical technologies pvt and stay connected to the pulse of your community

breast cancer: Gland Pharma gets USFDA nod for generic breast cancer drug

Gland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. It's expected to be the first generic approval in the market, with sales of around USD 92 million in the US.

Drug-administration , Orbicular-pharmaceutical-technologies-pvt-ltd , Gland-pharma , Eribulin-mesylate-injection , Orbicular-pharmaceutical-technologies-pvt , Breast-cancer , Usfda , Us-food-and-drug-administration , Iqvia ,